Results 111 to 120 of about 12,396 (213)

Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. [PDF]

open access: yesCurr Obes Rep
Tzeravini E   +4 more
europepmc   +1 more source

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue. [PDF]

open access: yesJ Med Chem
Fischer Munch H   +14 more
europepmc   +1 more source

Pancreatic hypersecretion of amyloid-forming human amylin dysregulates the neuro-immune axis and B cell development in a model of type-2 diabetes. [PDF]

open access: yesNeurobiol Dis
Winford ED   +14 more
europepmc   +1 more source

Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. [PDF]

open access: yesMol Metab
Briere DA   +17 more
europepmc   +1 more source

Modifiable Factors Affecting the Postprandial Glycemic Response. [PDF]

open access: yesJ Diabetes Sci Technol
Wu Y   +18 more
europepmc   +1 more source

Neuropeptide TIP39 as a pluripotent brain molecule and its potential functions in postpartum depression. [PDF]

open access: yesFront Endocrinol (Lausanne)
Wang S   +7 more
europepmc   +1 more source

Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]

open access: yesPhysiol Behav
Kern KA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy